0000950172-24-000249.txt : 20240506 0000950172-24-000249.hdr.sgml : 20240506 20240506171729 ACCESSION NUMBER: 0000950172-24-000249 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240506 FILED AS OF DATE: 20240506 DATE AS OF CHANGE: 20240506 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Virsik Peter CENTRAL INDEX KEY: 0001826322 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37410 FILM NUMBER: 24918632 MAIL ADDRESS: STREET 1: 131 ESCANYO WAY CITY: PORTOLA VALLEY STATE: CA ZIP: 94028 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ESSA Pharma Inc. CENTRAL INDEX KEY: 0001633932 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: SUITE 720 STREET 2: 999 WEST BROADWAY CITY: VANCOUVER STATE: A1 ZIP: V5Z 1K5 BUSINESS PHONE: (778) 331-0962 MAIL ADDRESS: STREET 1: SUITE 720 STREET 2: 999 WEST BROADWAY CITY: VANCOUVER STATE: A1 ZIP: V5Z 1K5 4 1 form4.xml X0508 4 2024-05-06 0001633932 ESSA Pharma Inc. EPIX 0001826322 Virsik Peter C/O ESSA PHARMA INC. 999 WEST BROADWAY, SUITE 720 VANCOUVER A1 V5Z 1K5 BRITISH COLUMBIA, CANADA true Chief Operating Officer true Common Shares 2024-05-06 4 S 0 694 6.95 D 11246 D The amount reflects the sale of shares pursuant to Mr. Virsik's 10b5-1 trading plan. The Rule 10b5-1 trading plan was entered into on August 31, 2023. The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. /s/ Peter Virsik 2024-05-06